protoporphyrin ix has been researched along with Mandibular Neoplasms in 1 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
Mandibular Neoplasms: Tumors or cancer of the MANDIBLE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We observed that two osteosarcoma cell lines from the same tumor displayed marked differences in their sensitivities to photodynamic therapy (PDT) with aminolevulinic acid hexyl ester (hALA-PDT)." | 7.75 | Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia. ( Matsumura, Y; Nomura, J; Tagawa, T; Watanabe, Y; Yanase, S, 2009) |
| "We observed that two osteosarcoma cell lines from the same tumor displayed marked differences in their sensitivities to photodynamic therapy (PDT) with aminolevulinic acid hexyl ester (hALA-PDT)." | 3.75 | Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia. ( Matsumura, Y; Nomura, J; Tagawa, T; Watanabe, Y; Yanase, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yanase, S | 1 |
| Nomura, J | 1 |
| Matsumura, Y | 1 |
| Watanabe, Y | 1 |
| Tagawa, T | 1 |
1 other study available for protoporphyrin ix and Mandibular Neoplasms
| Article | Year |
|---|---|
Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Combined Modality Therapy; Humans; Hyperthermia, Induced; Inf | 2009 |